Literature DB >> 23391492

Vav1 regulates MHCII expression in murine resting and activated B cells.

Bettina Jux1, Andrea Staratschek-Jox, Josef M Penninger, Joachim L Schultze, Waldemar Kolanus.   

Abstract

Vav1 is a guanine nucleotide exchange factor (GEF) for Rho GTPases, which is exclusively expressed in cells of the hematopoietic system. In addition to its well-documented GEF activity, it was suggested to have other functions due to the presence of multiple domains and nuclear localization signals in its protein structure. Although GEF-dependent and GEF-independent functions of vav have been implicated in T-cell development and T-cell receptor signaling, the role of vav1 in antigen-presenting cells is poorly understood. We found that vav1 is an important regulator of MHCII expression and transport. Microarray analysis of unstimulated bone marrow-derived macrophages revealed a novel role of vav1 in transcriptional regulation of the MHCII locus, possibly by indirect means. Primary immune cells from vav1-deficient mice had a significantly lower constitutive surface expression of MHCII with the strongest impact observed on splenic and peritoneal B cells. Impaired MHCII expression resulted in a diminished capacity for T-cell activation. Using 6-thio-GTP, a specific inhibitor of the GEF function of vav1, we were able to show that the GEF activity is required for MHCII upregulation in B cells after stimulation with LPS. Furthermore, our data show that vav1 not only affects transcription of the MHCII locus but also is an important regulator of MHCII protein transport to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391492     DOI: 10.1093/intimm/dxs157

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.

Authors:  A O Guerreiro-Cacais; U Norin; A Gyllenberg; R Berglund; A D Beyeen; E Petit-Teixeira; F Cornélis; A Saoudi; G J Fournié; R Holmdahl; L Alfredsson; L Klareskog; M Jagodic; T Olsson; I Kockum; L Padyukov
Journal:  Genes Immun       Date:  2017-01-05       Impact factor: 2.676

2.  Ezrin tunes the magnitude of humoral immunity.

Authors:  Debasis Pore; Neetha Parameswaran; Ken Matsui; Matthew B Stone; Ichiko Saotome; Andrea I McClatchey; Sarah L Veatch; Neetu Gupta
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

3.  Generating a transgenic mouse line stably expressing human MHC surface antigen from a HAC carrying multiple genomic BACs.

Authors:  Yoshinori Hasegawa; Tomoyuki Ishikura; Takanori Hasegawa; Takashi Watanabe; Junpei Suzuki; Manabu Nakayama; Yoshiaki Okamura; Tuneko Okazaki; Haruhiko Koseki; Osamu Ohara; Masashi Ikeno; Hiroshi Masumoto
Journal:  Chromosoma       Date:  2014-10-12       Impact factor: 4.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.